Though none of the studies previously conducted have reported any relationship between OMT administration and the total protein content, studies have reported its efficacy in lowering the levels of matrix metalloproteinases (MMPs) and albumin, both of which are found to be upregulated in the retinal layers during glaucoma and are important regulators of the AH outflow facility (48, 49). This evidence concerns the gene ALB and glaucoma.